Curative (company)

Last updated
Curative Inc.
Type Private
Industry Life sciences, biotechnology, medical diagnostics, healthcare industry
Founded2020 [1]
Founders
Headquarters
San Dimas, California [2]
Key people
Number of employees
>3000 [4]  (2021)
Website curative.com

Curative Inc. is a health care startup company best known for scaling COVID-19 testing and COVID-19 vaccinations during the COVID-19 pandemic. [5] In September 2022, Curative Inc. launched Curative Insurance Company, a new health insurance plan featuring no copays and no deductibles. Headquartered in Austin, Texas, with employees throughout the United States, [6] the company was founded in January 2020 by Fred Turner, Isaac Turner (no relation), and Vlad Slepnev to create new diagnostic tests for sepsis and to improve outcomes for sepsis patients. [6] In response to an urgent, unmet need for COVID-19 test development and production in the United States, [7] [8] Curative rapidly shifted focus in March 2020. [9] [10] The company's research team developed a new test for SARS-CoV-2 that utilized oral swabs rather than nasopharyngeal swabs. [11] [12] The Curative test was designed with a scalable process and opportunities to reduce healthcare worker exposure risk, and therefore the amount of personal protective equipment (PPE) used. [8] [13] An independent manufacturing and supply chain model was adopted to avoid competing with existing COVID-19 test companies for limited supplies and laboratory capacity. [8] [10] [14]

Contents

The United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Curative's SARS-CoV-2 Assay in April 2020. [14] [15] By October 2020, nearly 10% of the SARS-CoV-2 tests performed in the United States had been performed by Curative, [3] and the company's weekly test processing capacity reached one million tests per week. [1] [10] As of November 2020, Curative had administered more than 2 million tests in the city of Los Angeles, [16] and expanded service offerings to include test site management, test accessibility enhancements (kiosks, mobile vans), and efficient results reporting through proprietary software. [1] [10]

Starting in December 2020, Curative expanded its service to include COVID-19 vaccine distribution, vaccination site management, and vaccine management system for communities in the United States. [17] [18] [19] As of December 2022, Curative has administered over 35 million tests and administered 2 million vaccines through a network of affiliated providers.[ citation needed ]

In Q3 of 2022, Curative began the process of shutting down its COVID-19 testing business while simultaneously launching an employer-based health insurance offering**. Utilizing a new model for health insurance, the Curative plan has one monthly premium, and there are no additional costs for accessing medical services and most pharmaceuticals within their broad-based physician network and extensive drug formulary*. The health insurance plan is designed to focus on preventative care and total well-being through proactive relationship management for members. The PPO-network health insurance plan launched in late September 2022 out of Austin, Texas, with plans to expand across other areas of the state in 2023.

As of December 31, 2022, Curative has shut down its COVID-19 services business. In 2023, the company fully shifted its operations to its health insurance business.

History

In January 2020, Fred Turner, Isaac Turner (no relation), and Vlad Slepnev co-founded Curative, Inc. to create new diagnostic tools for the detection and management of sepsis. [6] In response to nationwide (US) shortages of diagnostic test kits, laboratory testing capacity, and personal protective equipment (PPE) available to healthcare workers, the company abruptly pivoted to focus on COVID-19 in March 2020. [3] [20] Curative developed a self-collected oral fluid swab [21] as an alternative sample collection method, [22] an orthogonal supply chain approach [1] [23] to avoid competing with other SARS-CoV-2/COVID-19 test kit and laboratory analysis providers, [10] [8] created the Curative SARS-CoV-2 Assay, and began field tests using supervised self-collection in Los Angeles and Long Beach (California) in March. [24] In early April, Curative contacted UK government officials, offering to supply 50,000 test kits per week. [25]

The company's novel RT-PCR-based Curative SARS-CoV-2 Assay received FDA Emergency Use Authorization (EUA) in April 2020. [15] [26] At the time the EUA was issued, tests were processed through a partnership between Curative and KorvaLabs; [27] the testing capacity was 5,000 tests per day, and the test kit manufacturing capacity was 20,000 per day. [26] Later in April 2020, the United States Department of Defense signed a US$13M agreement with Curative to source Curative SARS-CoV-2 Assay kits for Air Force use, to establish a new laboratory facility with testing capacity of 50,000 tests per day within one week of signing, and to establish additional test locations across the US at a later date. [15] By October 2020, the company had expanded operations, processing nearly 10% of the COVID-19 tests performed in the United States. [13] As of March 2021, Curative operated COVID-19 testing laboratories in San Dimas (California), Austin (Texas), and Washington, D.C. [28] [29]

After the Emergency Use Authorization had been issued, health care workers used Curative SARS-CoV-2 Assay to observe, direct, self-collect oral and nasal swabs, and subsequent laboratory analysis. The Curative SARS-CoV-2 Assay were implemented for medical diagnostic programs in the United States, including United States Armed Forces operations, [15] [30] prisons, [7] [31] state-wide nursing home, long-term care facilities, [32] city-wide centers, regional testing centers, [33] [34] state-wide testing programs, [35] [36] and airports. [37] The company partnered with universities to provide on-campus testing to students and/or student athletes (Texas A&M, [38] Florida A&M (Bragg Stadium), [38] [39] Western New Mexico University, [40] Our Lady of the Lake [41] ).

In July 2020, the United States Department of Defense awarded a CARES Act-funded contract (US$42M) to Curative to provide 250,000 test kits for use at more than 100 military treatment facilities, and analysis and reporting services at Curative's high throughput laboratory. [30]

In August, Florida officials signed a contract with Curative to provide COVID-19 testing services for staff at nursing home and long-term care facilities located throughout the state. [32] Using a biweekly testing schedule, the test positivity rate for staff members decreased from 3% to 1%. [42] The state later decided not to renew the contract following a federal government decision to ship rapid antigen detection test kits directly to facilities. [43] Subsequently, "a majority of the state's 694 nursing homes" entered into agreements with Curative to resume testing of staff and expand testing to include residents. [43]

In January 2021, the FDA released a Safety Communication warning the public of the risk of false negative results with the Curative test. [44] [45] The communication restated the patient populations, test uses, and other conditions that were previously validated and allowed under the original Emergency Use Authorization (EUA). [46] [47]

In late 2020, Curative piloted a drive-through influenza vaccine clinic at an existing Los Angeles SARS-CoV-2 testing site to evaluate the potential community benefits of combining large scale testing and vaccination services. [48] In December 2020, Curative began COVID-19 vaccine distribution in Los Angeles. [33] [49] By February 2021, the company's vaccine distribution and vaccine clinic management service had expanded to sites in California, [49] [50] Delaware, [51] Florida, [52] Massachusetts, [53] Michigan, [54] Pennsylvania, [55] [56] and Texas. [57] In February 2021, Curative made its proprietary Vaccine Management System software available for use by U.S. communities, without cost. [18]

Products

Curative SARS-CoV-2 Assay

The Curative SARS-CoV-2 Assay is a nucleic acid amplification test (NAAT), reverse transcription polymerase chain reaction test (RT-PCR) for COVID-19. The test was designed to be scalable in response to changes in demand, and uses a healthcare worker observed, self-collected oral fluid swab to obtain specimens for testing. During the self-collection procedure, a person coughs before swabbing the inside of their mouth to collect oral fluid for testing; the cough serves to release virus (if present) from the respiratory tract. The self-collected oral fluid swab method is less invasive than the nasopharyngeal swab method, [25] reduces the risk to healthcare workers by eliminating close contact, [10] and reduces the need to change PPE frequently. [10] The reduction in PPE usage was an advantage during the global shortage of medical materials related to the COVID-19 pandemic. [3] [14]

In July 2021, Curative switched over to using Abbott's Alinity m SARS-CoV-2 Assay and requested the FDA revoke EUA clearance for its original test. [58]

Curative testing site in Boyes Hot Springs, California in 2021. Curative COVID-19 testing site (Boyes Hot Springs, California) - 2021-10-20 - Sarah Stierch.jpg
Curative testing site in Boyes Hot Springs, California in 2021.

Accessible testing

After developing a scalable SARS-CoV-2 diagnostic test and laboratory facilities, Curative worked to make COVID-19 testing as accessible as possible. [59] The company partnered with cities, regions, and states across the United States, setting up and managing different types of testing sites (including drive-through, mobile vans, [60] kiosks, and walkup [61] locations) in an effort to reach general and at-risk populations. As of October 2021, Curative managed 16,557 testing sites nationwide, including mobile van, kiosk, walk-up, and drive-through sites. [62]

Vaccinations

In late 2020, Curative became one of the first companies to administer COVID-19 vaccines in Los Angeles, after vaccines from Pfizer and Moderna became publicly available in the United States. [49] Curative used the scaling principles that enabled it to quickly create mass and mobile COVID-19 testing capabilities to create a vaccine distribution and vaccination management strategy. [17] As of February 2021, the company had partnered with communities in California, [49] [50] Delaware, [51] Florida, [52] Massachusetts, [53] Michigan, [54] Pennsylvania, [55] [56] and Texas, [57] [63] administering over 2,000,000 vaccinations[ citation needed ] across 170 sites. Vaccination sites operated by the company include traditional, large scale (also known as mass vaccination), drive-through, [50] and mobile vans. [17] [53] [64] Also in February 2021, Curative made its proprietary Vaccine Management System software available to communities in the United States without cost. [18]

Awards

In 2020, Curative, Inc. was named a LinkedIn Top Startup, [65] and was the recipient of the 2020 dot.LA Summit Award “Pivot of the Year”. [20] In 2021, Curative was named Best Medtech Startup in the Medtech Breakthrough Awards, [66] was a finalist in the Pandemic Response category, and received an honorable mention in the Health category as part of our 2021 World Changing Ideas Awards by Fast Company. [67] [68] The company also received an honorable mention for Fast Company’s Best Place to Work for Innovators Award. [69]

Related Research Articles

<span class="mw-page-title-main">Seroconversion</span> Development of specific antibodies in the blood serum as a result of infection or immunization

In immunology, seroconversion is the development of specific antibodies in the blood serum as a result of infection or immunization, including vaccination. During infection or immunization, antigens enter the blood, and the immune system begins to produce antibodies in response. Before seroconversion, the antigen itself may or may not be detectable, but the antibody is absent. During seroconversion, the antibody is present but not yet detectable. After seroconversion, the antibody is detectable by standard techniques and remains detectable unless the individual seroreverts, in a phenomenon called seroreversion, or loss of antibody detectability, which can occur due to weakening of the immune system or decreasing antibody concentrations over time. Seroconversion refers the production of specific antibodies against specific antigens, meaning that a single infection could cause multiple waves of seroconversion against different antigens. Similarly, a single antigen could cause multiple waves of seroconversion with different classes of antibodies. For example, most antigens prompt seroconversion for the IgM class of antibodies first, and subsequently the IgG class.

DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2021, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano (Italy), Dietzenbach (Germany), Stillwater, Minnesota (US), Dartford (UK). Following the acquisition of Luminex, the company acquired five additional production plants located in the United States and in Canada (Toronto). The company is a constituent of the FTSE MIB index.

<span class="mw-page-title-main">COVID-19 pandemic in the United States</span>

In the United States, the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in 103,436,829 confirmed cases with 1,144,877 all-time deaths, the most of any country, and the 20th-highest per capita worldwide. The COVID-19 pandemic ranks first on the list of disasters in the United States by death toll; it was the third-leading cause of death in the U.S. in 2020, behind heart disease and cancer. From 2019 to 2020, U.S. life expectancy dropped by 3 years for Hispanic and Latino Americans, 2.9 years for African Americans, and 1.2 years for white Americans. These effects persisted as U.S. deaths due to COVID-19 in 2021 exceeded those in 2020, and life expectancy continued to fall from 2020 to 2021.

<span class="mw-page-title-main">COVID-19 testing</span> Diagnostic testing for SARS-CoV-2 virus infection

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.

<span class="mw-page-title-main">COVID-19 pandemic in Canada</span> Ongoing COVID-19 viral pandemic in Canada

The COVID-19 pandemic in Canada is part of the ongoing worldwide pandemic of coronavirus disease 2019. It is caused by severe acute respiratory syndrome coronavirus 2. Most cases over the course of the pandemic have been in Ontario, Quebec, British Columbia and Alberta. Confirmed cases have been reported in all of Canada's provinces and territories.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

<span class="mw-page-title-main">Moderna COVID-19 vaccine</span> RNA COVID-19 vaccine

The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in humans aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19, which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered in two or three 0.5-mL doses given by intramuscular injection at an interval of at least 28 days apart.

<span class="mw-page-title-main">COVID-19 drug development</span> Preventative and therapeutic medications for COVID-19 infection

COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 through 2021, several hundred drug companies, biotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID-19 disease in various stages of preclinical or clinical research, with 419 potential COVID-19 drugs in clinical trials, as of April 2021.

<span class="mw-page-title-main">Operation Warp Speed</span> US program to accelerate COVID-19 vaccine efforts

Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation Warp Speed was on April 29, 2020, and the program was officially announced on May 15, 2020. It was headed by Moncef Slaoui from May 2020 to January 2021 and by David A. Kessler from January to February 2021. At the end of February 2021, Operation Warp Speed was transferred into the responsibilities of the White House COVID-19 Response Team.

<span class="mw-page-title-main">Pfizer–BioNTech COVID-19 vaccine</span> Type of vaccine for humans

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in humans to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) encoding a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial advice indicated that vaccination required two doses given 21 days apart, but the interval was later extended to up to 42 days in the US, and up to four months in Canada.

<span class="mw-page-title-main">Janssen COVID-19 vaccine</span> Vaccine against COVID-19

The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson.

<span class="mw-page-title-main">History of COVID-19 vaccine development</span> Scientific work to develop a vaccine for COVID-19

SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.

<span class="mw-page-title-main">COVID-19 vaccination in the United States</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen vaccine was granted emergency use authorization on February 27, 2021. By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over.

<span class="mw-page-title-main">United States responses to the COVID-19 pandemic</span> Actions by the United States regarding the COVID-19 pandemic

The United States' response to the COVID-19 pandemic with consists of various measures by the medical community; the federal, state, and local governments; the military; and the private sector. The public response has been highly polarized, with partisan divides being observed and a number of concurrent protests and unrest complicating the response.

Seegene, Inc is a Korean manufacturer of in vitro diagnostic (IVD) products, particularly molecular diagnostics. Its portfolio includes a range of assays and screening products for sepsis, respiratory diseases such as influenza and respiratory syncytial virus, as well as sexually transmitted infections (STIs). It was founded in 2000. In early 2020, it began developing and distributing a range of tests for SARS-CoV-2, the virus that causes COVID-19.

<span class="mw-page-title-main">Carbon Health</span> American healthcare company

Carbon Health is an American chain of primary healthcare and urgent care clinics that also provides telemedicine. It was founded in 2015 in San Francisco.

<span class="mw-page-title-main">COVID-19 vaccine clinical research</span> Clinical research to establish the characteristics of COVID-19 vaccines

COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy, effectiveness, and safety. As of November 2022, 40 vaccines are authorized by at least one national regulatory authority for public use:

<span class="mw-page-title-main">COVID-19 vaccine misinformation and hesitancy</span> Misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it

Anti-vaccination activists and other people in many countries have spread a variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines based on misunderstood or misrepresented science, religion, and law. These have included exaggerated claims about side effects, misrepresentations about how the immune system works and when and how COVID-19 vaccines are made, a story about COVID-19 being spread by 5G, and other false or distorted information. This misinformation has proliferated and may have made many people averse to vaccination. This has led to governments and private organizations around the world introducing measures to incentivize or coerce vaccination, such as lotteries, mandates, and free entry to events, which has in turn led to further misinformation about the legality and effect of these measures themselves.

<span class="mw-page-title-main">COVID-19 vaccination mandates in the United States</span> Mandates for people to receive the COVID-19 vaccine in the U.S.

Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and also by private entities. In September 2021, President Joe Biden announced that the federal government would take steps to mandate COVID-19 vaccination for certain entities under the authority of the federal government or federal agencies. Most federal mandates thus imposed were either overturned through litigation, or withdrawn by the administration, although a mandate on health care workers in institutions receiving Medicare and Medicaid funds was upheld. All federal mandates were lifted when the national emergency was declared to have ended in May 2023. A small number of states have gone in the opposite direction, through executive orders or legislation designed to limit vaccination mandates.

References

'*A Baseline Visit is required of members in order to qualify for no copays and no deductibles for in-network care and preferred prescriptions throughout the calendar year.

'** Curative Insurance Company

  1. 1 2 3 4 5 6 "COVID-19 Testing at Scale while Reimagining Healthcare". Cell Systems . 11 (4): 329–330. 21 October 2020. doi:10.1016/j.cels.2020.09.010. PMC   7577258 . Archived from the original on 6 April 2023. Retrieved 15 November 2020.
  2. ↑ Uranga, Rachel (26 Mar 2020). "'They Are Desperately Trying to Hire': Inside Curative's Race to Produce 10K COVID-19 Test Kits a Day". dot.la . USA. Archived from the original on 21 October 2020. Retrieved 8 November 2020.
  3. 1 2 3 4 Dwyer, Devin (17 October 2020). "COVID-19 testing capacity outpacing desire to get swabbed". ABC News . USA. Archived from the original on 8 November 2020. Retrieved 8 November 2020.
  4. ↑ "Curative Overview". Glassdoor . Glassdoor, Inc. 2021. Archived from the original on 26 April 2022. Retrieved 19 March 2021.
  5. ↑ Regardie, Jon (19 March 2021). "What L.A. Got Right and What's Gone Wrong Since the First Safer at Home Order". Archived from the original on 20 March 2021. Retrieved 24 March 2021.
  6. 1 2 3 Fortson, Danny (17 May 2020). "Oxford dropout's winning test for Covid‑19". The Times . Archived from the original on 17 January 2021. Retrieved 8 November 2020.
  7. 1 2 "Texas deploys self-administered tests to inmates". Fox 13 News . USA. 13 May 2020. Archived from the original on 18 May 2020. Retrieved 23 November 2020.
  8. 1 2 3 4 Farr, Christina (2 August 2020). "Covid-19 testing delays create a public health nightmare as schools and workplaces try to reopen". CNBC . Archived from the original on 10 November 2020. Retrieved 8 November 2020.
  9. ↑ Jack Fink, Fred Turner. Texas Sending 80K Oral Swab Tests For COVID-19 To DOJ. CBS News. Archived from the original on July 2, 2021.
  10. 1 2 3 4 5 6 7 Ashlee Vance, Fred Turner. College-Dropout CEO Bets It All on New Covid Test (Video). Bloomberg Businessweek (Bloomberg L.P.). Retrieved 16 October 2020.
  11. ↑ Kojima, N; Turner, F; Slepnev, V; Bacelar, A; Deming, L; Kodeboyina, S; Klausner, JD (2021). "Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for Coronavirus Disease 2019 Detection". Clinical Infectious Diseases. 73 (9): e3106–e3109. doi:10.1093/cid/ciaa1589. PMC   7665422 . PMID   33075138.
  12. ↑ Marty, FM; Chen, K; Verrill, KA (28 May 2020). "How to Obtain a Nasopharyngeal Swab Specimen". New England Journal of Medicine . 328 (22): 376. doi: 10.1056/nejmvcm2010260 . PMID   32302471. S2CID   215809594.
  13. 1 2 "Wellness -- Inside one of the largest COVID-19 testing labs". Good Morning America . USA. 18 October 2020. Archived from the original on 22 March 2021. Retrieved 27 March 2021.
  14. 1 2 3 Shieber, Jonathan (18 Apr 2020). "Curative received FDA emergency use authorization for its novel COVID-19 tests". TechCrunch . Archived from the original on 7 March 2021. Retrieved 27 March 2021.
  15. 1 2 3 4 Rogers, James (23 Apr 2020). "Air Force signs deal for COVID-19 oral tests". Fox News . USA. Archived from the original on 9 November 2020. Retrieved 21 November 2020.
  16. ↑ Billington, Francesca (20 November 2020). "COVID Testing Won't Make Thanksgiving 'Safe', Experts Warn". dot.la . Archived from the original on 20 November 2020. Retrieved 23 November 2020.
  17. 1 2 3 Darmiento, Laurence; Petersen, Melody (24 March 2021). "COVID-19 turned a tiny start-up into a testing giant. But can its results be trusted?". Los Angeles Times . Los Angeles. Archived from the original on 24 March 2021. Retrieved 24 March 2021.
  18. 1 2 3 "Curative Offers Revolutionary Vaccination Management Software to Streamline Delivery Efforts: Curative's Proprietary Software Collects, Organizes, and Distributes Information to Support the National Vaccination Process & at No Cost to Vaccine Administrators". Morningstar, Inc. 11 February 2021. Retrieved 22 March 2021.[ permanent dead link ]
  19. ↑ Staff (June 16, 2021). "Curative Expands Testing Options For COVID-19, Flu And RSV Across Nationwide Healthcare Delivery Network". The Street. Archived from the original on October 22, 2021. Retrieved October 22, 2021.
  20. 1 2 Uranga, Rachel (28 October 2020). "GoodRx Is Named Startup of the Year at dot.LA Summit Awards". dot.la . USA. Archived from the original on 27 November 2020. Retrieved 1 November 2020.
  21. ↑ Temple, James (5 May 2020). "Can the US ramp up coronavirus testing? California will provide clues". MIT Technology Review . Massachusetts Institute of Technology. Archived from the original on 28 November 2020. Retrieved 1 November 2020.
  22. ↑ Tuller, David (6 October 2020). "Easier-to-use COVID saliva tests start to catch on". Modern Healthcare . Crain Communications. Archived from the original on 5 November 2020. Retrieved 17 November 2020.
  23. ↑ Tapp, Tom (6 July 2020). "Los Angeles Coronavirus Update: Sean Penn's CORE And Test Company Curative Step In To Meet Increased Demand At Dodger Stadium Testing Site – Updated". Deadline Hollywood . Archived from the original on 6 December 2020. Retrieved 21 November 2020.
  24. ↑ Hale, Conor (20 Apr 2020). "FDA greenlights oral fluid test for COVID-19". Fierce Biotech. USA. Archived from the original on 28 November 2020. Retrieved 21 November 2020.
  25. 1 2 Halliday, Josh (29 Apr 2020). "UK turned down offer of 10,000 tests a day four weeks ago". The Guardian . UK. Archived from the original on 8 January 2021. Retrieved 15 November 2020.
  26. 1 2 Shieber, Jonathan (18 Apr 2020). "Curative received FDA emergency use authorization for its novel COVID-19 tests". Yahoo! Finance . Archived from the original on 6 April 2023. Retrieved 8 November 2020.
  27. ↑ Uranga, Rachel (13 Mar 2020). "L.A. Venture Capital Firm MarsBio Scrambles to Secure Cash, Resources for Coronavirus Vaccines, Test Kits". dot.la . Archived from the original on 31 October 2020. Retrieved 8 November 2020.
  28. ↑ Capritto, Amanda (21 March 2021). "Where to get a COVID-19 test for travel". CNET . Archived from the original on 26 March 2021. Retrieved 27 March 2021.
  29. ↑ de Nobel, Jacob (10 December 2020). "Testing Their Mettle". Johns Hopkins University . Johns Hopkins University Office of Communications. Archived from the original on 22 April 2021. Retrieved 27 March 2021.
  30. 1 2 "DOD Announces Contract for 250,000 Curative Inc. COVID-19 Test Kits". defense.gov. United States Department of Defense. 31 July 2020. Archived from the original on 21 November 2020. Retrieved 21 November 2020.
  31. ↑ McCullough, Jolie (14 May 2020). "Texas is spending $45 million on new coronavirus tests that prisoners are administering to themselves: The state purchased 300,000 oral swab tests from a months-old California company. So far, only highly-infected prisons are using them for mass testing". Archived from the original on 25 November 2020. Retrieved 23 November 2020.
  32. 1 2 "Florida nursing homes to get rapid COVID-19 tests". WFTV . Florida, USA. 9 August 2020. Archived from the original on 5 October 2020. Retrieved 17 November 2020.
  33. 1 2 Chandler, Jenna (4 January 2021). "Diagnostics Startup Curative Is Testing Thousands of Angelenos for Covid Every Day". Los Angeles Business Journal. Archived from the original on 8 May 2021. Retrieved 27 March 2021.
  34. ↑ Pratt, Gregory (11 May 2020). "Chicago to open six more testing sites in neighborhoods, will work with actor Sean Penn's charity to try reaching goal of 10,000 tests per day". Chicago Tribune . Archived from the original on 5 November 2020. Retrieved 23 November 2020.
  35. ↑ Osborne, Peter (11 May 2020). "Businesses wait to see if $30M test expansion spurs reopening". Delaware Business Times. USA. Archived from the original on 14 April 2021. Retrieved 21 March 2021.
  36. ↑ Schmidt, Sophia (15 May 2020). "Taking COVID-19 testing to a new level". Delaware Public Media. Archived from the original on 19 May 2020. Retrieved 18 November 2020.
  37. ↑ "Lightfoot, CDPH announce new COVID-19 testing site at Midway Airport, winterization plan". Fox32 . 18 November 2020. Archived from the original on 24 November 2020. Retrieved 22 November 2020.
  38. 1 2 Helker, Jacob (14 July 2020). "Texas A&M system makes COVID-19 testing available to students, faculty, staff". ABC7 News. Archived from the original on 15 July 2020. Retrieved 23 November 2020.
  39. ↑ Skerritt, Andrew (14 October 2020). "FAMU Bragg Stadium COVID-19 Site Announces Operational Changes". FAMU Forward. Florida. Archived from the original on 25 October 2020. Retrieved 8 November 2020.
  40. ↑ "Western New Mexico University acquiring rapid testing for COVID-19". Deming Headlight. 19 November 2020. Archived from the original on 19 November 2020. Retrieved 23 November 2020.
  41. ↑ Speelman, Eric (November 2020). "OLLU, Curative bring COVID test site to campus". Archived from the original on 19 November 2020. Retrieved 23 November 2020.
  42. ↑ Sexton, Christine (16 September 2020). "Florida cuts back on some nursing home safeguards that protected sites from COVID". Sun-Sentinel . Florida, USA. Archived from the original on 21 September 2020. Retrieved 20 November 2020.
  43. 1 2 Sexton, Christine (1 October 2020). "Nursing homes, firm plan staff COVID-19 testing". WJXT . Florida, USA. Archived from the original on 20 October 2020. Retrieved 19 November 2020.
  44. ↑ "Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication". fda.gov. Food and Drug Administration. 4 January 2021. Archived from the original on 4 January 2021. Retrieved 12 March 2021.
  45. ↑ Fabiano, Amelia (8 January 2021). "FDA warns about risk of false-negative results with Curative COVID-19 tests". NBC News . USA. Archived from the original on 11 January 2021. Retrieved 25 March 2021.
  46. ↑ "FDA Issues Safety Communication about Risk of False Results with the Curative SARS-CoV-2 Test for COVID-19". cdc.gov. Centers for Disease Control and Prevention. 6 January 2021. Archived from the original on 21 March 2021. Retrieved 15 March 2021.
  47. ↑ Lee, Stephanie M. (15 January 2021). "The FDA Warned Curative's Popular COVID Test Could Be Faulty. Here's What We Know So Far". BuzzFeed . Archived from the original on 11 April 2021. Retrieved 22 March 2021.
  48. ↑ Kojima, Noah; Turner, Isaac; Klausner, Jeffrey D. (18 February 2021). "The Covid-19 Vaccine-Development Multiverse". New England Journal of Medicine . 384 (7): 681–2. doi: 10.1056/NEJMc2034838 . S2CID   231768387.
  49. 1 2 3 4 "L.A. County, City of L.A., Curative Announce Partnership to Vaccinate Residents and Staff at Nursing Homes". County of Los Angeles, California . County of Los Angeles, California. 2020. Archived from the original on 20 March 2021. Retrieved 19 March 2021.
  50. 1 2 3 Masciadrelli, Mike (28 January 2021). "Curative COVID vaccine running Eastfield Mall site is ready for opening day". WWLP news . Springfield, Massachusetts, USA. Archived from the original on 21 February 2021. Retrieved 22 March 2021.
  51. 1 2 "Governor Carney, DPH, DEMA Announce Updates on COVID-19 Vaccination Program". Delaware.gov. 9 February 2021. Archived from the original on 2 March 2021. Retrieved 24 March 2021.
  52. 1 2 Guerrero, Andrea (16 May 2021). "New vaccination site to open in Cape Coral". WINK-TV . Florida, USA. Archived from the original on 2 June 2021. Retrieved 1 June 2021.
  53. 1 2 3 Trowbridge, Ryan; Landaverde, Briceyda (3 March 2021). "Curative responds to President Biden's vaccination goal". westernmassnews.com. Archived from the original on 21 March 2021. Retrieved 24 March 2021.
  54. 1 2 Fonger, Ron (11 May 2021). "Genesee County replacing two COVID-19 vaccination mega sites with one". mlive.com. Michigan, USA. Archived from the original on 2 June 2021. Retrieved 2 June 2021.
  55. 1 2 Larussa, Tony (24 May 2021). "Covid vaccination clinic in Franklin Park booking appointments online". Pittsburgh Tribune-Review . USA. Archived from the original on 24 May 2021. Retrieved 4 June 2021.
  56. 1 2 Wadas, Amy (13 May 2021). "Laser Show Set Up At Canonsburg COVID-19 Vaccine Clinic". KDKA-TV . USA. Archived from the original on 4 June 2021. Retrieved 4 June 2021.
  57. 1 2 "Dell Diamond to serve as COVID-19 vaccination site: Round Rock Express partner with Curative, Williamson County to distribute vaccine at no cost". Round Rock, Texas . City of Round Rock. 11 March 2021. Archived from the original on 11 March 2021. Retrieved 19 March 2021.
  58. ↑ "FDA revokes approval of Curative COVID-19 test". Los Angeles Times . 17 July 2021. Archived from the original on 17 July 2021. Retrieved 17 July 2021.
  59. ↑ Uranga, Rachel (20 July 2020). "Beyond Drive-Thrus: Why Curative Wants to Take COVID Testing to Mobile Vans and Vending Machines". dot.LA. USA. Archived from the original on 17 May 2021. Retrieved 24 March 2021.
  60. ↑ Gross, Kristi (12 February 2021). "'Open for all': Local Sikh temples to host COVID-19 testing vans". Fox40 (Fox News). California, USA. Archived from the original on 25 February 2021. Retrieved 22 March 2021.
  61. ↑ "Clay County extends vaccine partnership with Curative". Clay Today. Florida, USA. 2 June 2021. Archived from the original on 4 June 2021. Retrieved 4 June 2021.
  62. ↑ "Sclae - Impact Report". Official website - Curative. Archived from the original on 2021-10-22. Retrieved 2021-10-22.
  63. ↑ Camacho, Brenda (12 March 2021). "City partners with Curative to administer vaccines". KGNS-TV . Laredo, Texas. Archived from the original on 24 September 2021. Retrieved 27 March 2021.
  64. ↑ Anderson, Katie (13 April 2021). "Curative opens mobile testing sites in Canonsburg, North Strabane". Observer–Reporter . Archived from the original on 4 June 2021. Retrieved 4 June 2021.
  65. ↑ Hempel, Jessi (22 September 2020). "LinkedIn Top Startups 2020: The 50 U.S. companies on the rise". linkedin.com. LinkedIn Corporation. Archived from the original on 22 July 2021. Retrieved 11 November 2020.
  66. ↑ "2021 Winners". medtechbreakthrough.com. MedTech Breakthrough Awards. 2021. Archived from the original on 14 June 2021. Retrieved 3 June 2021.
  67. ↑ "World Changing Ideas Awards 2021: Pandemic Response Finalists and Honorable Mentions". Fast Company . Mansueto Ventures LLC. 4 May 2021. Archived from the original on 1 June 2021. Retrieved 4 June 2021.
  68. ↑ "World Changing Awards 2021: Health Finalists and Honorable Mentions". Fast Company . Mansueto Ventures LLC. 4 May 2021. Archived from the original on 31 May 2021. Retrieved 4 June 2021.
  69. ↑ Staff (4 August 2021). "Five large companies earn Best Workplaces for Innovators recognition". Fast Company . Archived from the original on 22 October 2021. Retrieved 22 October 2021.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.